(+)-schisandrin B multiple interactions ISO Mtarc2 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MTARC2 mRNA] CTD PMID:31150632 1,2,4-trimethylbenzene decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 pseudocumene results in decreased expression of MTARC2 protein CTD PMID:17337753 1,2-dimethylhydrazine decreases expression ISO Mtarc2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MTARC2 mRNA CTD PMID:22206623 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MTARC2 mRNA CTD PMID:20106945 and PMID:21632981 2,4-dinitrotoluene affects expression ISO Mtarc2 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of MTARC2 mRNA CTD PMID:21346803 3-chloropropane-1,2-diol decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in decreased expression of MTARC2 protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MTARC2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MTARC2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of MTARC2 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MTARC2 mRNA CTD PMID:28628672 6-propyl-2-thiouracil decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of MTARC2 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of MTARC2 mRNA CTD PMID:22100608 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of MTARC2 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of MTARC2 mRNA CTD PMID:33167477 ammonium chloride affects expression ISO Mtarc2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of MTARC2 mRNA CTD PMID:16483693 benzamidoxime multiple interactions EXP 6480464 [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of benzamidoxime CTD PMID:22924387 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of MTARC2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of MTARC2 mRNA CTD PMID:32234424 bisphenol A affects expression ISO Mtarc2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of MTARC2 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MTARC2 protein CTD PMID:34186270 bisphenol A decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of MTARC2 mRNA CTD PMID:34947998 Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of MTARC2 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MTARC2 mRNA CTD PMID:28628672 buspirone increases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Buspirone results in increased expression of MTARC2 mRNA CTD PMID:24136188 cadmium dichloride increases expression ISO Mtarc2 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of MTARC2 mRNA CTD PMID:24982889 cadmium dichloride decreases methylation ISO Mtarc2 (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased methylation of MTARC2 promoter CTD PMID:22457795 cadmium dichloride affects methylation ISO Mtarc2 (Rattus norvegicus) 6480464 Cadmium Chloride affects the methylation of MTARC2 promoter CTD PMID:22457795 cadmium dichloride increases methylation ISO Mtarc2 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased methylation of MTARC2 promoter CTD PMID:22457795 carbon nanotube decreases expression ISO Mtarc2 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of MTARC2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to MTARC2 gene] CTD PMID:28238834 clofibrate decreases expression ISO Mtarc2 (Mus musculus) 6480464 Clofibrate results in decreased expression of MTARC2 mRNA CTD PMID:17585979 copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MTARC2 mRNA CTD PMID:20971185 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MTARC2 mRNA CTD PMID:20971185 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of MTARC2 mRNA CTD PMID:20106945 and PMID:25562108 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MTARC2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MTARC2 mRNA CTD PMID:28628672 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression EXP 6480464 entinostat results in increased expression of MTARC2 mRNA CTD PMID:26272509 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTARC2 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO Mtarc2 (Mus musculus) 6480464 epoxiconazole results in increased expression of MTARC2 mRNA CTD PMID:35436446 flavonoids decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of MTARC2 mRNA CTD PMID:18035473 flutamide decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of MTARC2 mRNA CTD PMID:24136188 glafenine decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of MTARC2 mRNA CTD PMID:24136188 Heptachlor epoxide decreases expression ISO Mtarc2 (Mus musculus) 6480464 Heptachlor Epoxide results in decreased expression of MTARC2 mRNA CTD PMID:25270620 hypochlorous acid decreases expression ISO Mtarc2 (Mus musculus) 6480464 Hypochlorous Acid results in decreased expression of MTARC2 mRNA CTD PMID:19376150 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MTARC2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MTARC2 mRNA CTD PMID:28628672 methamphetamine affects response to substance EXP 6480464 MTARC2 gene SNP affects the susceptibility to Methamphetamine CTD PMID:18316681 N(4)-hydroxycytidine multiple interactions EXP 6480464 [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine CTD PMID:22924387 NAD zwitterion multiple interactions EXP 6480464 [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine CTD PMID:25170804 NAD(+) multiple interactions EXP 6480464 [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine CTD PMID:25170804 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of MTARC2 mRNA CTD PMID:24768652 and PMID:25583101 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of MTARC2 mRNA CTD PMID:22714537 panobinostat increases expression EXP 6480464 Panobinostat results in increased expression of MTARC2 mRNA CTD PMID:26272509 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTARC2 mRNA CTD PMID:27188386 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MTARC2 mRNA CTD PMID:25704631 paracetamol affects expression ISO Mtarc2 (Mus musculus) 6480464 Acetaminophen affects the expression of MTARC2 mRNA CTD PMID:17562736 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of MTARC2 mRNA CTD PMID:23146750 phenobarbital decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of MTARC2 mRNA CTD PMID:19162173 pirinixic acid decreases expression ISO Mtarc2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of MTARC2 mRNA CTD PMID:20813756 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sulfamethoxazole hydroxylamine multiple interactions EXP 6480464 [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine CTD PMID:25170804 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of MTARC2 mRNA CTD PMID:33359661 tetrachloromethane decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of MTARC2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO Mtarc2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of MTARC2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions ISO Mtarc2 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MTARC2 mRNA] CTD PMID:31150632 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of MTARC2 mRNA CTD PMID:22378314 thimerosal decreases expression EXP 6480464 Thimerosal results in decreased expression of MTARC2 mRNA CTD PMID:27188386 trichloroethene increases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of MTARC2 mRNA CTD PMID:19448997 triptonide increases expression ISO Mtarc2 (Mus musculus) 6480464 triptonide results in increased expression of MTARC2 mRNA CTD PMID:33045310 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of MTARC2 mRNA CTD PMID:22378314 undecane decreases expression ISO Mtarc2 (Rattus norvegicus) 6480464 undecane results in decreased expression of MTARC2 protein CTD PMID:17337753 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MTARC2 mRNA CTD PMID:19101580 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of MTARC2 mRNA CTD PMID:25979313 valproic acid increases expression ISO Mtarc2 (Mus musculus) 6480464 Valproic Acid results in increased expression of MTARC2 mRNA CTD PMID:20546886 and PMID:21427059 valproic acid affects expression ISO Mtarc2 (Mus musculus) 6480464 Valproic Acid affects the expression of MTARC2 mRNA CTD PMID:17292431 zearalenone increases expression ISO Mtarc2 (Mus musculus) 6480464 Zearalenone results in increased expression of MTARC2 protein CTD PMID:25058043 zinc atom increases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of MTARC2 mRNA CTD PMID:12672911 zinc(0) increases expression ISO Mtarc2 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of MTARC2 mRNA CTD PMID:12672911